What does Preamble of Closing the HPV Testing Gap Act do?

This bill directs the Director of the National Institutes of Health (NIH) to conduct a study. The study's focus is on the development of a standardized, noninvasive test for Human Papillomavirus (HPV) in men. The NIH Director is required to submit a report on the study's findings to Congress.

What does SHORT TITLE. of Closing the HPV Testing Gap Act do?

This bill is formally titled the 'Closing the HPV Testing Gap Act'.

What does FINDINGS. of Closing the HPV Testing Gap Act do?

This section outlines findings related to human papillomavirus (HPV). HPV is identified as the most common sexually transmitted infection in the United States, with a notable proportion of HPV-related cancers occurring in men. Currently, there is no HPV diagnostic test for men approved by the Food and Drug Administration. A 2023 report by the National Academies of Sciences, Engineering, and Medicine highlights the importance of coordinated cancer prevention strategies. Expanding HPV detection to include men is suggested to promote gender equity in cancer prevention and improve public health outcomes. The lack of a standardized HPV diagnostic test for men is linked to sustained transmission and delayed detection, impacting women's health and cervical cancer incidence.

What does NIH STUDY AND REPORT ON DEVELOPMENT OF STANDARDIZED, of Closing the HPV Testing Gap Act do?

This section directs the Director of the National Institutes of Health (NIH) to conduct a comprehensive study on the development of a standardized, noninvasive test for human papillomavirus (HPV) in men. The study must be completed within 24 months of the Act's enactment and involves consultation with various agencies and experts. The study will assess the current state of development, explore potential testing methodologies (including oral, pharyngeal, anal, penile, and urine testing), and consider future implementation strategies. The Director of NIH is tasked with developing recommendations for interagency coordination to facilitate regulatory approval, community-based screening, and equitable access to the test. An interagency working group will be established to coordinate scientific, regulatory, and community implementation pathways throughout the study. Within 30 months of enactment, the Director of NIH must submit a report to Congress detailing the study's findings, recommendations, and interagency strategies for integrating HPV testing into national initiatives. The study will also assess the feasibility of pilot and implementation studies across diverse populations and multiple sites affected by HPV.

Back to bills

Closing the HPV Testing Gap Act

Last updated: 5/20/2026 · Introduced: 5/20/2026

Author: LaMonica McIver (D-NJ)

TL;DR (AI)

This bill mandates a two-year study by the National Institutes of Health (NIH) focused on developing a standardized, noninvasive HPV test for men.
The NIH study will evaluate various testing methods, assess feasibility across diverse populations, and develop recommendations for regulatory approval and equitable access.
The NIH Director must submit a report to Congress within 30 months detailing the study's findings, recommendations, and interagency strategies for HPV testing integration.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 2 more.

4 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account